Bipolar FRF Tx for acne in Japanese deemed safe, effective

Bipolar FRF tx for acne in japanese deemed safe, effective

(HealthDay)—Bipolar fractional radiofrequency (FRF) therapy appears to be effective for atrophic acne scars and acne among Japanese patients, according to a study published online April 9 in the Journal of Dermatology.

Chikako Kaminaka, M.D., from Wakayama Medical University in Japan, and colleagues evaluated the safety and efficacy of bipolar FRF therapy as a treatment for atrophic scars and acne vulgaris. Twenty-three Japanese patients were treated with a bipolar FRF system, undergoing five treatment sessions at one-month intervals. After the final treatment, patients were followed for three months.

The researchers observed marked improvements in scar volume among patients with mild scars. In 57.5 percent of the treated areas, the improvement was at least moderate. At each time point, the treated areas exhibited significantly fewer lesions compared with baseline (P < 0.05). At the end of the study there were significant improvements in patients' assessments of the treatment outcomes and their quality of life. In addition, there were significant reductions noted in patients' sebum levels, skin roughness, and scar depth.

"The findings of this study suggest that bipolar FRF is effective against atrophic acne scars and acne in Japanese and has minimal side-effects," the authors write.

The study was funded by JMEC.


Explore further

Treatment interval doesn't affect benefit of acne laser Tx

More information: Abstract
Full Text (subscription or payment may be required)

Copyright © 2015 HealthDay. All rights reserved.

Citation: Bipolar FRF Tx for acne in Japanese deemed safe, effective (2015, April 13) retrieved 22 January 2020 from https://medicalxpress.com/news/2015-04-bipolar-frf-tx-acne-japanese.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
2 shares

Feedback to editors

User comments